Vietnam Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032

Vietnam Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A19518
Buy Now

Market Overview:

Vietnam biologics market size is projected to exhibit a growth rate (CAGR) of 7.06% during 2024-2032. The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, continuous investments in its healthcare infrastructure, and the expanding elderly population represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 7.06%


Biologics, also known as biopharmaceuticals or biological drugs, are a class of pharmaceutical products produced using living cells, such as bacteria, yeast, and mammalian or human cells, in specialized bioreactors. They are large and structurally complex molecules, often consisting of amino acids or nucleic acids, which can be challenging to produce and characterize. They often require careful handling and storage conditions to maintain their structural and functional integrity. They target specific proteins, receptors, or cells in the body, leading to a more targeted and precise therapeutic effect. They can act through various mechanisms, including inhibiting or enhancing immune responses, replacing missing or dysfunctional proteins, or modulating specific biological pathways. They can be tailored to individual patients, increasing their therapeutic potential and minimizing adverse effects. They often have a more favorable safety profile compared to traditional drugs, as they are less likely to interact with unrelated molecules in the body. They are widely used to treat autoimmune disorders like rheumatoid arthritis, Crohn's disease, and psoriasis. Besides this, they are also employed in the treatment of infectious diseases, including biologics and antiviral therapies. Moreover, as they are effective in managing skin diseases such as psoriasis and eczema, the demand for biologics is increasing across Vietnam.

Vietnam Biologics Market Trends:

The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, in Vietnam represents one of the primary factors facilitating the market growth. Biologics offer effective treatment options for these conditions, catalyzing the demand in the market. Additionally, the expanding elderly population in the country is offering a favorable market outlook. Biologics are often used to manage age-related diseases, further fueling the market growth. Moreover, advances in biotechnology and bioprocessing techniques are making the development and production of biologics more feasible in Vietnam. This is leading to increased local production and reduced reliance on imports. The introduction of biosimilars, which are highly similar but not identical to existing biologics, is providing more affordable treatment options and increased competition in the market. Furthermore, Vietnam is actively collaborating with international pharmaceutical companies and research institutions to leverage their expertise in biologics development and manufacturing. Besides this, governing authorities of the country are providing support for local biopharmaceutical companies engaged in research and development (R&D) activities. This includes tax incentives, grants, and subsidies to encourage innovation in biologics. In addition, the evolution of the regulatory framework for biologics in Vietnam is streamlining approval processes and ensuring safety and efficacy. Moreover, the emergence of patient advocacy groups in Vietnam that focus on various chronic diseases is increasing awareness among the masses about biologic therapies.

Vietnam Biologics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on source, product, disease, and manufacturing.

Source Insights:

  • Microbial
  • Mammalian
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the source. This includes microbial, mammalian, and others.

Product Insights:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others
     

A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes monoclonal antibodies, vaccines, recombinant proteins, antisense RNAi and molecular therapy, and others.

Disease Insights:

  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the disease. This includes oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others.

Manufacturing Insights:

  • Outsourced
  • In-House
     

A detailed breakup and analysis of the market based on the manufacturing have also been provided in the report. This includes outsourced and in-house.

Regional Insights:

  • Northern Vietnam
  • Central Vietnam
  • Southern Vietnam
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Biologics Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Source
  • Product
  • Disease
  • Manufacturing
  • Region
Sources Covered Microbial, Mammalian, Others
Products Covered Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, Others
Diseases Covered Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others
Manufacturings Covered Outsourced, In-House
Regions Covered Northern Vietnam, Central Vietnam, Southern Vietnam
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Vietnam biologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Vietnam biologics market?
  • What is the breakup of the Vietnam biologics market on the basis of source?
  • What is the breakup of the Vietnam biologics market on the basis of product?
  • What is the breakup of the Vietnam biologics market on the basis of disease?
  • What is the breakup of the Vietnam biologics market on the basis of manufacturing?
  • What are the various stages in the value chain of the Vietnam biologics market? 
  • What are the key driving factors and challenges in the Vietnam biologics?
  • What is the structure of the Vietnam biologics market and who are the key players?
  • What is the degree of competition in the Vietnam biologics market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam biologics market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam biologics market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam biologics industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Vietnam Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More